title: Genetic diversity among Enterococcus faecalis.
abstract: Enterococcus faecalis, a ubiquitous member of mammalian gastrointestinal flora, is a leading cause of nosocomial infections and a growing public health concern. The enterococci responsible for these infections are often resistant to multiple antibiotics and have become notorious for their ability to acquire and disseminate antibiotic resistances. In the current study, we examined genetic relationships among 106 strains of E. faecalis isolated over the past 100 years, including strains identified for their diversity and used historically for serotyping, strains that have been adapted for laboratory use, and isolates from previously described E. faecalis infection outbreaks. This collection also includes isolates first characterized as having novel plasmids, virulence traits, antibiotic resistances, and pathogenicity island (PAI) components. We evaluated variation in factors contributing to pathogenicity, including toxin production, antibiotic resistance, polymorphism in the capsule (cps) operon, pathogenicity island (PAI) gene content, and other accessory factors. This information was correlated with multi-locus sequence typing (MLST) data, which was used to define genetic lineages. Our findings show that virulence and antibiotic resistance traits can be found within many diverse lineages of E. faecalis. However, lineages have emerged that have caused infection outbreaks globally, in which several new antibiotic resistances have entered the species, and in which virulence traits have converged. Comparing genomic hybridization profiles, using a microarray, of strains identified by MLST as spanning the diversity of the species, allowed us to identify the core E. faecalis genome as consisting of an estimated 2057 unique genes.
authors.affiliation: Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
authors.forename: Shonna M
authors.initials: SM
authors.lastname: McBride
authors.forename: Vincent A
authors.initials: VA
authors.lastname: Fischetti
authors.forename: Donald J
authors.initials: DJ
authors.lastname: Leblanc
authors.forename: Robert C
authors.initials: RC
authors.lastname: Moellering
authors.forename: Michael S
authors.initials: MS
authors.lastname: Gilmore
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019295:Computational Biology; D013293:Enterococcus faecalis / Q000145:classification / Q000235:genetics* / Q000472:pathogenicity; D041981:Gastrointestinal Tract / Q000382:microbiology; D014644:Genetic Variation; D005838:Genotype; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D010802:Phylogeny; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D011634:Public Health; D012703:Serotyping / Q000379:methods
chemical_list: D000900:Anti-Bacterial Agents